250 related articles for article (PubMed ID: 35305696)
1. Siah-1-interacting protein regulates mutated huntingtin protein aggregation in Huntington's disease models.
Latoszek E; Wiweger M; Ludwiczak J; Dunin-Horkawicz S; Kuznicki J; Czeredys M
Cell Biosci; 2022 Mar; 12(1):34. PubMed ID: 35305696
[TBL] [Abstract][Full Text] [Related]
2. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
3. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
[TBL] [Abstract][Full Text] [Related]
4. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.
Hakim-Eshed V; Boulos A; Cohen-Rosenzweig C; Yu-Taeger L; Ziv T; Kwon YT; Riess O; Phuc Nguyen HH; Ziv NE; Ciechanover A
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18661-18669. PubMed ID: 32675242
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-modifying enzymes in Huntington's disease.
Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA
Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
[TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs.
Tong H; Yang T; Liu L; Li C; Sun Y; Jia Q; Qin Y; Chen L; Zhao X; Zhou G; Yan S; Li XJ; Li S
Neurobiol Dis; 2023 Oct; 187():106291. PubMed ID: 37716514
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.
Wang B; Zeng L; Merillat SA; Fischer S; Ochaba J; Thompson LM; Barmada SJ; Scaglione KM; Paulson HL
Neurobiol Dis; 2018 Jan; 109(Pt A):127-136. PubMed ID: 28986324
[TBL] [Abstract][Full Text] [Related]
9. Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington's disease-related phenotype.
Long J; Luo X; Fang D; Song H; Fang W; Shan H; Liu P; Lu B; Yin XM; Hong L; Li M
Cell Biosci; 2022 Oct; 12(1):167. PubMed ID: 36209136
[TBL] [Abstract][Full Text] [Related]
10. NAADP-Evoked Ca
Pereira CAS; Medaglia NC; Ureshino RP; Bincoletto C; Antonioli M; Fimia GM; Piacentini M; Pereira GJDS; Erustes AG; Smaili SS
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982672
[TBL] [Abstract][Full Text] [Related]
11. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.
Zhao T; Hong Y; Li S; Li XJ
J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006
[TBL] [Abstract][Full Text] [Related]
12. Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons.
Tian J; Yan YP; Zhou R; Lou HF; Rong Y; Zhang BR
Neurosci Bull; 2014 Feb; 30(1):74-80. PubMed ID: 24362588
[TBL] [Abstract][Full Text] [Related]
13. Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.
Fiorillo A; Morea V; Colotti G; Ilari A
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945781
[TBL] [Abstract][Full Text] [Related]
14. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
15. Molecular Strategies to Target Protein Aggregation in Huntington's Disease.
Jarosińska OD; Rüdiger SGD
Front Mol Biosci; 2021; 8():769184. PubMed ID: 34869596
[TBL] [Abstract][Full Text] [Related]
16. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
17. Thiol-disulfide Oxidoreductases TRX1 and TMX3 Decrease Neuronal Atrophy in a Lentiviral Mouse Model of Huntington's Disease.
Fox J; Lu Z; Barrows L
PLoS Curr; 2015 Nov; 7():. PubMed ID: 26664998
[TBL] [Abstract][Full Text] [Related]
18. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
Liu Y; Hettinger CL; Zhang D; Rezvani K; Wang X; Wang H
J Neurochem; 2014 May; 129(3):539-47. PubMed ID: 24383989
[TBL] [Abstract][Full Text] [Related]
20. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]